Tag: Series

Grin Therapeutics Secures $140M in Series D Funding Round

Summary: Grin Therapeutics, Inc. secured a $140 million Series D financing, with a significant investment from Angelini Pharma

Creatify Secures $15.5M in Series A Investment

Summary: Creatify, a Mountain View-based company, secured $15.5M in Series A funding led by WndrCo and Kindred Ventures.

The Wizarding World Unveiled: Updates on the Harry Potter TV Series

The blog discusses Warner Bros. Discovery's upcoming Harry Potter series on HBO's streaming service, Max. It covers the

RevenueCat Secures $50 Million in Series C Investment

Summary: RevenueCat, a platform for managing consumer app monetization, raised $50M in Series C funding led by Bain

Fore Biotherapeutics Secures $38 Million in Series D-2 Funding

Summary: Fore Biotherapeutics, a biotherapeutics company based in Philadelphia, secured $38M in Series D-2 financing to develop targeted

Siro Secures $50M in Series B Investment Round

Summary: Siro, a NYC-based provider of AI-powered conversation intelligence platform for in-person sales, secured $50M in Series B

Slash Secures $41 Million in Series B Funding Round

Summary: Slash, a banking platform provider based in San Francisco, raised $41M in Series B funding at a

Clair Secures $23M in Series B Funding to Fuel Growth and Expansion

Clair Raises $23M in Series B Funding for Earned Wage Access Solutions Summary: NYC-based fintech company Clair secures

Recruitment Platform Flo Recruit Secures Series A Investment

Summary: Flo Recruit, a legal talent software company based in Austin, TX, secured an undisclosed amount in Series

Biostate AI Secures $12M in Series A Funding for Growth and Expansion

Biostate AI Secures $12M in Series A Funding Summary: Biostate AI, a Houston-based artificial intelligence and RNA sequencing

Novisto Secures $27M in Series C Investment Round

Summary: Novisto, a sustainability reporting software company based in Montreal, Canada, secured $27M in Series C funding. The

CellCentric Secures $120 Million in Series C Financing

CellCentric Secures $120M in Series C Funding CellCentric, a biotechnology company based in Cambridge, UK, has successfully raised